On March 24, 2026, Advent International signed a definitive agreement to acquire a majority stake in Salt & Stone, the Los Angeles premium body-care brand that did roughly $165 million in 2025 revenue. Terms were not disclosed, the founder is staying, and the deal signals where private equity wants to spend in premium DTC.
- Salt & Stone is a profitable, three-channel brand: a top deodorant at Sephora and Amazon, with direct-to-consumer at about 40 percent of sales.
- A majority stake with the founder staying means real money off the table now and equity kept in a larger next outcome, in exchange for a return clock.
- Advent ran this exact play with Olaplex, which it sold to Henkel for about $1.4 billion in 2026. Body care is its kind of platform.
- The lesson for founders: profitable growth, balanced channels, and a brand that does not depend on one channel or one person is what gets a control buyer to pay up.
On March 24, 2026, Advent International signed a definitive agreement to take a majority stake in Salt & Stone, the Los Angeles body-care and fragrance brand. Terms were not disclosed. The deal was set to close in April, and founder Nima Jalali and his senior team are staying to run the company. Read past the press release and it is one of the cleaner signals you will get all year about what private equity wants in premium consumer.
I read deals like this for a living and I have closed one from the buy side. A few years back I sourced and closed a several-hundred-million-dollar DTC acquisition for an S&P 500 company. That meant building the model, defending the price in front of an investment committee, and watching what a founder does in the eighteen months after the wire clears. When I look at Salt & Stone, I read a deal structure more than a beauty story, and the structure tells you almost everything.
Salt & Stone did about $165 million in revenue in 2025 with double-digit growth across channels, and roughly 40 percent of that is direct-to-consumer across the US, Canada and the UK. It is a top deodorant at both Sephora and Amazon. Those are the numbers of a real business with margin and repeat purchase, which is precisely the profile a sponsor like Advent will pay a full price for. The wider pattern is in the 2026 consumer brand acquisitions roundup, and the category-level pricing is in the beauty brand acquisition multiples breakdown.
I will go through what Advent bought, why body care and why now, what the founder-stays structure trades, and what earned the multiple. Then comes what to take from it if you run a DTC brand that might one day get the same phone call. None of the deal terms here are made up, and where a number is not public, I say so.
What Advent actually
bought, and what
it did not disclose.
Start with the facts. Advent signed to acquire a majority stake, not the whole company. The price was not disclosed, so anyone quoting a specific enterprise value or multiple is guessing. What is public is the shape of the business, and the shape is what matters.
| Dimension | What is public |
|---|---|
Buyer | Advent International (majority stake) |
Announced | March 24, 2026, expected to close April 2026 |
2025 revenue | Roughly $165M, double-digit growth across channels |
Channel mix | DTC ~40% (US, Canada, UK); top deodorant at Sephora and Amazon |
Founder | Nima Jalali (founded 2017), staying with senior team |
Price / multiple | Not disclosed |
The table has no price in it. Advent did not put out an enterprise value, and Salt & Stone is private, so there is no public mark. Read the coverage for the profile, which you can see: a nine-year-old brand at $165 million with profitable growth and a balanced channel mix is a control buyer's dream, and that is what got it bought.
One more piece of context frames the whole thing. Advent already owned Olaplex, took it from a salon-niche product to a global prestige hair brand, and sold it to Henkel for about $1.4 billion in 2026. Salt & Stone is the next entry in a deliberate premium personal-care strategy, and it makes the most sense read that way.
Why body care, and
why a sponsor wants
it in 2026.
Body care is not glamorous, and that is exactly why private equity likes it. Deodorant, soap, lotion, and fragrance are things people buy again without thinking, at a premium price, with gross margins that hold up. Strip the hype out of beauty and you are left with a few categories that combine repeat purchase, pricing power, and a clear strategic buyer at the end. Premium personal care is one of them.
The repeat-purchase point is the one founders underrate. A brand that sells a deodorant every few seconds is not paying to reacquire that customer each month the way a one-and-done apparel brand does. That changes the unit economics entirely, and it is why a body-care brand can carry real contribution margin while a fashion brand at the same revenue struggles to. The category mechanics behind that are in the unit economics by category piece.
"Private equity does not buy a vibe. It buys a cash flow with a story attached. Salt & Stone has both, and the cash flow came first."
Most operators forget to think about the exit logic. A sponsor buys a brand it can sell again, usually to a strategic acquirer. Premium body care has exactly that kind of buyer waiting: the Henkels, Unilevers, and L'Oréals of the world are short on credible, founder-built premium brands and will pay up for one that has already proven it can scale. The sponsor's bet is to buy a profitable brand, fund it, professionalize it, and hand it to a strategic in five to seven years. Body care supports that round trip, and that explains most of the timing.
The founder stays.
That word is doing
a lot of work.
The line in the release that founders should sit with is that Jalali and the senior team are staying. A majority stake with the founder rolling over sets the whole deal architecture, and it changes what the founder signed up for in ways that are easy to miss in the celebration.
None of that is a knock on the deal. For a founder who has carried a brand from nothing to $165 million, a structured majority sale with a rollover is often the smartest move available: it banks a life-changing outcome and keeps upside in the second act. See the trade for what it is: you are neither selling a brand and walking away nor keeping it and taking some cash off the top. You are trading control for capital and a partner, and committing to a return clock. Going in with eyes open decides whether the eighteen months after close feel like fuel or like a leash.
What actually earned
the multiple, even
unpriced.
The number is private, so I will not invent one. But you do not need the exact multiple to see what drove it, because the value drivers are public and they are the same ones I underwrote when I was buying brands. Four things make a premium consumer brand worth a premium price, and Salt & Stone has all four.
| Driver | Why it moves the price |
|---|---|
Profitable growth | Double-digit growth that throws off cash, not growth bought with losses. Sponsors price the EBITDA, not the topline story. |
Channel diversity | DTC, Sephora, and Amazon all material. No single channel can sink the brand, which de-risks the model. |
Repeat category | Deodorant and body care reorder on their own. Retention is structural, not a CRM trick. |
Strategic exit path | A clear next buyer (a strategic in personal care) means the sponsor can underwrite a clean round trip. |
Profitable growth is the one that separates a brand that gets bought from a brand that gets a polite pass. A sponsor underwrites to cash flow, so the question is how much of that growth dropped to the bottom line, not how fast you grew. When a brand needs ever-larger paid budgets to hold its number, it is buying that revenue, and buyers can see it instantly. The teardown logic is in the DTC profitability teardown, and the EBITDA threshold that makes a brand sellable at all is in the sellable-margin piece.
Channel diversity is the underrated driver in this deal. A brand that is 40 percent DTC and also a top seller at Sephora and Amazon is structurally safer than a pure-play DTC brand living and dying on one paid channel. If Meta costs spike, the retail business carries it, and if a retailer gets cautious, DTC carries it. That balance is what lets a buyer model a steady cash flow instead of a fragile one, and steady cash flow is what gets paid a premium. The opposite case, the single-channel brand that looks great until the channel turns, is the one that gets repriced in diligence.
This is the Olaplex
playbook, run again
in a new category.
To understand what Advent intends to do with Salt & Stone, look at what it just did with Olaplex. Advent owned Olaplex, scaled it from a salon-centric hair product into a global prestige brand across professional, retail, and DTC channels, and then sold it to Henkel for about $1.4 billion in 2026. That is the template, and Salt & Stone fits it almost exactly, one category over.
The Olaplex round trip tells you the moves to expect. Expand distribution, push international, professionalize the operation, and build the brand into something a strategic acquirer has to own. None of that requires a new playbook, only capital, patience, and a brand with enough demand to absorb the expansion, which is the asset Advent just bought. Salt & Stone is already strong at Sephora and Amazon, so the international and distribution levers are right there to pull.
The same playbook has a failure mode, and the Olaplex story has one too. Scaling a founder-built brand inside a sponsor's growth plan can dilute the very thing that made it special, and a brand that loses its identity in the expansion does not command the same exit. The risk in the Salt & Stone deal is whether the brand keeps its voice while Advent scales it. Brands that lose that voice are the ones a strategic walks away from, which is the same dynamic I cover in why enterprises lose to DTC challengers. Founders staying is the hedge against exactly this, which is probably why it was a condition of the deal.
What a DTC founder
should actually take
from this deal.
If you run a DTC brand and you ever want this phone call, the Salt & Stone profile is the spec sheet, and what you copy is the shape of the business rather than the category. A sponsor like Advent is buying a business that throws off cash and depends on neither one channel nor one person. Build toward that and you make yourself the kind of brand that gets the inbound, on your terms, instead of having to go shop yourself when growth stalls.
Build real margin as you grow the topline. The single biggest thing that separated Salt & Stone from the brands that get a pass is profitable growth. Buyers underwrite EBITDA. If your growth only pencils with ever-rising paid spend, what you have is a media account, and it is not a sellable business yet. Get your contribution margin and your blended payback to a place where the brand funds itself, and only then are you in the room. The realistic version of what that exit looks like is in the realistic DTC exit piece.
Diversify your channels before you need to. The brands that get repriced in diligence are the single-channel ones. Get into retail, get onto Amazon, and keep DTC strong, so no one channel is more than roughly half your revenue. That balance makes the business operationally safer, and it is worth real money at exit because it lets a buyer model a steady cash flow. The brands fighting for that balance are the same incumbents in the enterprise-versus-challenger dynamic, and the ones that win it get bought.
Make the brand bigger than the founder. Salt & Stone's founder is staying, but the brand had to be a real business that could outlast any one person for a control buyer to pay full price. Build the team, document the playbook, and make sure the demand is for the brand, not for your personal feed. A brand that collapses if the founder leaves gets priced at a discount. The wider M&A backdrop these brands are selling into is in the consumer acquisitions roundup.
Beauty being hot explains less of this deal than what private equity has always paid for: profitable growth, diversified channels, a repeat-purchase product, and a clean path to a strategic buyer. This deal applies it to a category that finally has enough founder-built premium brands to buy. Advent paid up for a cash flow with a story attached, and the cash flow came first. Founders have to get that order right, and it is the whole lesson of this deal.
A sponsor pays for profitable growth, a sound channel mix and a team that runs without the founder. That is the work I do with founders who want their brand to read like this in two or three years.
What founders ask me
about the Salt & Stone
deal.
Salt & Stone is owned by Advent International, which took a majority stake in the deal it signed on March 24, 2026. Founder Nima Jalali keeps a minority stake and stays on to run the brand with his senior team. Terms were not disclosed, so the exact split and price are not public.
Advent signed a definitive agreement on March 24, 2026 to acquire a majority stake in Salt & Stone, the Los Angeles premium body-care and fragrance brand founded in 2017 by Nima Jalali. Terms were not disclosed. The deal was expected to close in April 2026, with the founder and senior management staying to lead the company.
Salt & Stone logged roughly $165 million in revenue in 2025 with double-digit growth across channels. Its direct-to-consumer business across the US, Canada and UK is about 40 percent of sales, and it is a top deodorant brand at both Sephora and Amazon. That balanced three-channel mix is part of why a sponsor like Advent paid up. The category math is in the unit economics by category piece.
It means the sponsor owns control, sets the board, and runs the value-creation plan, while the founder keeps a meaningful minority stake and an operating role. The founder takes real money off the table now and keeps equity in the next, larger outcome. The trade is autonomy: the brand now answers to a return clock it did not have before.
Premium personal care is one of the few consumer categories with strong margins, repeat purchase, and a clear strategic buyer at the end. Advent ran this exact play with Olaplex, which it sold to Henkel for about $1.4 billion in 2026. A profitable body-care brand with retail and DTC reach is a clean platform to scale and then sell to a strategic. The wider pattern is in the beauty brand multiples breakdown.
Sponsors pay premiums for profitable growth, channel diversity, and a brand that does not depend on one founder or one platform. Build real margin, do not let any single channel exceed roughly half of revenue, and make the business legible. The Salt & Stone profile, balanced channels and durable demand, is what gets a control buyer to pay up. The realistic exit math is in the realistic DTC exit piece.
Wondering what your brand is worth to a buyer like this?
I co-founded a brand portfolio that scaled to nine-figure revenue, and I sourced and closed a several-hundred-million-dollar DTC acquisition on the corporate buy side. I have built the model, defended the price, and lived the year after the wire clears. If you are weighing a sale, a majority recap, or just want to know what makes a buyer pay up, that is the view I bring.
Start a conversation See the case studies →A note on sources: the March 24, 2026 agreement for Advent International to acquire a majority stake in Salt & Stone, the no-disclosed-terms structure, the expected April 2026 close, and the founder-stays condition are from Advent's own announcement and WWD. The roughly $165 million 2025 revenue, double-digit channel growth, ~40 percent DTC mix across the US, Canada and UK, and top-deodorant status at Sephora and Amazon are from Business of Fashion and Retail Dive. Advent's prior ownership and roughly $1.4 billion sale of Olaplex to Henkel in 2026 is from Advent. The price and multiple on Salt & Stone were not disclosed, so I have not estimated them. The read on the structure, the value drivers, and the founder playbook is mine, from co-founding a nine-figure brand portfolio and closing a DTC acquisition on the corporate buy side.